multiple

(redirected from Multiple organ dysfunction syndrome)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to Multiple organ dysfunction syndrome: SIRS

Price-Earnings Ratio

The price of a security per share at a given time divided by its annual earnings per share. Often, the earnings used are trailing 12 month earnings, but some analysts use other forms. The P/E ratio is a way to help determine a security's stock valuation, that is, the fair value of a stock in a perfect market. It is also a measure of expected, but not realized, growth. Companies expected to announce higher earnings usually have a higher P/E ratio, while companies expected to announce lower earnings usually have a lower P/E ratio. See also: PEG

multiple

1. In stock-index futures, the number multiplied by the futures price to determine the value of the contract. For example, the $500 multiple of the Standard & Poor's Midcap Index is multiplied by the futures price to determine the value of one contract. Thus, a futures price of $230 would yield a contract value of $115,000 ($500 × $230).

Multiple.

A stock's multiple is its price-to-earnings ratio (P/E). It's figured by dividing the market price of the stock by the company's earnings.

The earnings could be the actual earnings for the past four quarters, called a trailing P/E. Or they might be the actual figures for the past two quarters plus an analyst's projection for the next two, called a forward P/E.

Investors use the multiple as a way to assess whether the price they are paying for the stock is justified by its earnings potential. The higher the multiple they are willing to accept, the higher their expectations for the stock.

However, some investors reject stocks with higher multiples, since it may be impossible for the stock to meet the market's expectations.

References in periodicals archive ?
Research: Multiple organ dysfunction syndrome (MODS) is a major cause of mortality in intensive care units.
The results of [the] study indicated a restricted red cell transfusion strategy is as safe as and not inferior to a liberal strategy with respect to incidence and severity of multiple organ dysfunction syndrome," said Dr.
Significantly greater reductions in multiple organ dysfunction syndrome scores and chest radiograph scores were observed in the treatment group.
NIEHS grantee Michael Karin of the University of San Diego, California, and colleagues sought to elucidate the role of NF-[kappa]B in severe systemic inflammation and multiple organ dysfunction syndrome (MODS).

Full browser ?